Respiratory Syncytial Virus Nosode 4033 NDC 63083-4033

NDC codes

FDA NDC Directory

Product NDC (as listed)63083-4033Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63083-4033Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63083-4033-2	63083403302	59 mL in 1 BOTTLE, DROPPER (63083-4033-2)Marketed from Aug 15, 1985

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Respiratory Syncytial Virus Nosode 4033Suffix: 4033
Generic name (nonproprietary): respiratory syncytial virus nosode
Active ingredients: Human respiratory syncytial virus — 12 [hp_X]/59mL
Dosage form: Liquid
Route: Oral
Labeler: Professional Complementary Health Formulas
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Aug 15, 1984
Listing expires: Dec 31, 2027
Identifiers: Product ID 63083-4033_366b6f1c-8044-4c77-a0bd-694d27265025SPL ID 366b6f1c-8044-4c77-a0bd-694d27265025SPL set ID 1c9a3509-8810-4ec6-a101-01b5ee924fbeUNII 0980L90RNP

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463083403302 followed by a unit qualifier and the quantity

Package 63083-4033-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 8, 2026.

Indications (excerpt from the label)

INDICATIONS For the temporary relief of cough, stuffy or runny nose, mild sore throat, or minor earache.*

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)